Spectrum Cannabis, wholly owned subsidiary of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced this morning the launch of its new color-coded Softgels to customers in Canada. Spectrum Cannabis has created this new product to offer consumers a safe alternative to smoking cannabis for relief. This will allow healthcare professionals the ability to give patients a controlled dose of cannabinoids for a wide range of conditions.
Spectrum will be offering different colors coded softgels that contain different ratios of THC and CBD which will help individuals and health care professionals identify the ratio that will be beneficial for certain conditions. The company is meeting the growing demand for easy to use cannabis derived products.
The new product is being manufactured at Spectrum’s Smiths Falls GMP-1 certified industrial size production campus. Canopy Growth Corporation is making a commitment to be able to provide its customers a consistent supply of the new product that is now available for purchase today.
Mark Zekulin, President, Canopy Growth gave this statement in the press release:
“Launching Spectrum Cannabis Softgels embodies our ongoing commitment to medical customers. Spectrum Cannabis will continue to offer the best products available with a focus on innovative, easy-to-dose and understand options. Delivering these new, extract based Softgels is another success as we focus on providing solutions for the patients who depend on medical cannabis and the healthcare professionals who prescribe it.”